Annual EBIT
-$141.72 M
+$61.33 M+30.20%
31 December 2023
Summary:
Fortress Biotech annual earnings before interest & taxes is currently -$141.72 million, with the most recent change of +$61.33 million (+30.20%) on 31 December 2023. During the last 3 years, it has fallen by -$48.57 million (-52.15%). FBIO annual EBIT is now -1365.69% below its all-time high of -$9.66 million.FBIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$24.39 M
+$2.94 M+10.77%
30 September 2024
Summary:
Fortress Biotech quarterly earnings before interest & taxes is currently -$24.39 million, with the most recent change of +$2.94 million (+10.77%) on 30 September 2024. Over the past year, it has dropped by -$15.68 million (-180.14%). FBIO quarterly EBIT is now -1071.42% below its all-time high of -$2.08 million, reached on 30 September 2010.FBIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$115.84 M
-$15.68 M-15.66%
30 September 2024
Summary:
Fortress Biotech TTM earnings before interest & taxes is currently -$115.84 million, with the most recent change of -$15.68 million (-15.66%) on 30 September 2024. Over the past year, it has increased by +$52.76 million (+31.29%). FBIO TTM EBIT is now -5463.98% below its all-time high of -$2.08 million, reached on 30 September 2010.FBIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBIO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.2% | -180.1% | +31.3% |
| 3 y3 years | -52.1% | +42.1% | -8.2% |
| 5 y5 years | -17.6% | -11.9% | -25.2% |
FBIO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -52.1% | +30.2% | -180.1% | +62.1% | -15.7% | +45.7% |
| 5 y | 5 years | -52.2% | +30.2% | -180.1% | +62.1% | -26.2% | +45.7% |
| alltime | all time | -1365.7% | +30.2% | -1071.4% | +62.1% | -5464.0% | +45.7% |
Fortress Biotech EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.39 M(-10.8%) | -$115.84 M(+15.7%) |
| June 2024 | - | -$27.33 M(-26.2%) | -$100.16 M(-21.1%) |
| Mar 2024 | - | -$37.03 M(+36.7%) | -$126.92 M(-10.4%) |
| Dec 2023 | -$141.72 M(-30.2%) | -$27.09 M(+211.2%) | -$141.72 M(-15.9%) |
| Sept 2023 | - | -$8.71 M(-83.9%) | -$168.61 M(-19.8%) |
| June 2023 | - | -$54.10 M(+4.4%) | -$210.12 M(+1.3%) |
| Mar 2023 | - | -$51.83 M(-4.0%) | -$207.35 M(+2.1%) |
| Dec 2022 | -$203.05 M(+32.7%) | -$53.98 M(+7.5%) | -$203.05 M(-4.9%) |
| Sept 2022 | - | -$50.22 M(-2.2%) | -$213.48 M(+3.9%) |
| June 2022 | - | -$51.33 M(+8.0%) | -$205.40 M(+16.5%) |
| Mar 2022 | - | -$47.52 M(-26.2%) | -$176.29 M(+15.3%) |
| Dec 2021 | -$152.96 M(+64.2%) | -$64.41 M(+52.9%) | -$152.96 M(+42.9%) |
| Sept 2021 | - | -$42.14 M(+89.6%) | -$107.02 M(+16.6%) |
| June 2021 | - | -$22.23 M(-8.1%) | -$91.80 M(-4.0%) |
| Mar 2021 | - | -$24.19 M(+30.9%) | -$95.64 M(+2.7%) |
| Dec 2020 | -$93.14 M(+0.0%) | -$18.47 M(-31.4%) | -$93.14 M(-13.6%) |
| Sept 2020 | - | -$26.92 M(+3.3%) | -$107.84 M(+5.0%) |
| June 2020 | - | -$26.06 M(+20.2%) | -$102.73 M(+1.7%) |
| Mar 2020 | - | -$21.69 M(-34.6%) | -$101.04 M(+7.8%) |
| Dec 2019 | -$93.13 M(-22.7%) | -$33.17 M(+52.1%) | -$93.75 M(+1.3%) |
| Sept 2019 | - | -$21.80 M(-10.6%) | -$92.53 M(-6.8%) |
| June 2019 | - | -$24.37 M(+69.2%) | -$99.30 M(-1.8%) |
| Mar 2019 | - | -$14.41 M(-54.9%) | -$101.13 M(-16.5%) |
| Dec 2018 | -$120.46 M(+34.1%) | -$31.94 M(+11.8%) | -$121.12 M(+9.6%) |
| Sept 2018 | - | -$28.57 M(+9.0%) | -$110.48 M(-3.9%) |
| June 2018 | - | -$26.20 M(-23.8%) | -$115.00 M(+4.2%) |
| Mar 2018 | - | -$34.40 M(+61.5%) | -$110.36 M(+22.5%) |
| Dec 2017 | -$89.83 M | -$21.31 M(-35.6%) | -$90.08 M(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$33.09 M(+53.4%) | -$88.22 M(+23.6%) |
| June 2017 | - | -$21.57 M(+52.8%) | -$71.40 M(+8.7%) |
| Mar 2017 | - | -$14.11 M(-27.4%) | -$65.69 M(-3.4%) |
| Dec 2016 | -$67.60 M(+29.0%) | -$19.45 M(+19.6%) | -$67.97 M(+7.6%) |
| Sept 2016 | - | -$16.27 M(+2.6%) | -$63.14 M(-4.9%) |
| June 2016 | - | -$15.86 M(-3.2%) | -$66.38 M(+17.3%) |
| Mar 2016 | - | -$16.39 M(+12.1%) | -$56.59 M(+7.9%) |
| Dec 2015 | -$52.40 M(+175.1%) | -$14.62 M(-25.0%) | -$52.42 M(+26.7%) |
| Sept 2015 | - | -$19.50 M(+221.5%) | -$41.38 M(+57.1%) |
| June 2015 | - | -$6.07 M(-50.4%) | -$26.34 M(+5.9%) |
| Mar 2015 | - | -$12.22 M(+241.4%) | -$24.87 M(+30.6%) |
| Dec 2014 | -$19.05 M(-45.9%) | -$3.58 M(-19.9%) | -$19.05 M(-23.2%) |
| Sept 2014 | - | -$4.47 M(-2.6%) | -$24.80 M(-10.4%) |
| June 2014 | - | -$4.59 M(-28.3%) | -$27.66 M(-16.8%) |
| Mar 2014 | - | -$6.40 M(-31.4%) | -$33.26 M(-5.6%) |
| Dec 2013 | -$35.23 M(+30.8%) | -$9.33 M(+27.1%) | -$35.23 M(+3.3%) |
| Sept 2013 | - | -$7.34 M(-27.9%) | -$34.12 M(+4.9%) |
| June 2013 | - | -$10.19 M(+21.5%) | -$32.53 M(+13.0%) |
| Mar 2013 | - | -$8.38 M(+2.0%) | -$28.79 M(+6.8%) |
| Dec 2012 | -$26.94 M(-25.8%) | -$8.21 M(+42.8%) | -$26.94 M(+6.9%) |
| Sept 2012 | - | -$5.75 M(-10.6%) | -$25.20 M(+9.7%) |
| June 2012 | - | -$6.44 M(-1.5%) | -$22.98 M(+13.3%) |
| Mar 2012 | - | -$6.54 M(+1.0%) | -$20.28 M(-44.1%) |
| Dec 2011 | -$36.29 M(+275.3%) | -$6.47 M(+83.3%) | -$36.29 M(+11.2%) |
| Sept 2011 | - | -$3.53 M(-5.5%) | -$32.63 M(+4.6%) |
| June 2011 | - | -$3.74 M(-83.4%) | -$31.18 M(+13.6%) |
| Mar 2011 | - | -$22.55 M(+700.0%) | -$27.45 M(+460.1%) |
| Dec 2010 | -$9.67 M | -$2.82 M(+35.4%) | -$4.90 M(+135.4%) |
| Sept 2010 | - | -$2.08 M | -$2.08 M |
FAQ
- What is Fortress Biotech annual earnings before interest & taxes?
- What is the all time high annual EBIT for Fortress Biotech?
- What is Fortress Biotech annual EBIT year-on-year change?
- What is Fortress Biotech quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Fortress Biotech?
- What is Fortress Biotech quarterly EBIT year-on-year change?
- What is Fortress Biotech TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Fortress Biotech?
- What is Fortress Biotech TTM EBIT year-on-year change?
What is Fortress Biotech annual earnings before interest & taxes?
The current annual EBIT of FBIO is -$141.72 M
What is the all time high annual EBIT for Fortress Biotech?
Fortress Biotech all-time high annual earnings before interest & taxes is -$9.66 M
What is Fortress Biotech annual EBIT year-on-year change?
Over the past year, FBIO annual earnings before interest & taxes has changed by +$61.33 M (+30.20%)
What is Fortress Biotech quarterly earnings before interest & taxes?
The current quarterly EBIT of FBIO is -$24.39 M
What is the all time high quarterly EBIT for Fortress Biotech?
Fortress Biotech all-time high quarterly earnings before interest & taxes is -$2.08 M
What is Fortress Biotech quarterly EBIT year-on-year change?
Over the past year, FBIO quarterly earnings before interest & taxes has changed by -$15.68 M (-180.14%)
What is Fortress Biotech TTM earnings before interest & taxes?
The current TTM EBIT of FBIO is -$115.84 M
What is the all time high TTM EBIT for Fortress Biotech?
Fortress Biotech all-time high TTM earnings before interest & taxes is -$2.08 M
What is Fortress Biotech TTM EBIT year-on-year change?
Over the past year, FBIO TTM earnings before interest & taxes has changed by +$52.76 M (+31.29%)